# PIK3CA Mutational Status Assessment

> **NCT06706570** · — · RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 100 (estimated)

## Conditions studied

- Breast Cancer Metastatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06706570
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-06
- **Primary completion:** 2026-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06706570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06706570, "PIK3CA Mutational Status Assessment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06706570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*